跳至主要内容
临床试验/CTRI/2020/06/025647
CTRI/2020/06/025647尚未招募3 期

Comparing platelet inhibition with crushed versus integral pill administration of clopidogrel and ticagrelor in patients with acute coronary syndrome undergoing percutaneous intervention

Fluid Research Fund0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients presenting within 12 hours from the onset of symptoms with ACS as per ACC/AHA criteria and undergoing PCI.
  • Patients giving informed consent obtained in writing.

排除标准

  • Age < 18 years or Age > 75 years.
  • Inability to give informed consent.
  • Active bleeding; bleeding diathesis; coagulopathy
  • History of GI, I.C, genitourinary or other site abnormal bleeding < 3 months
  • Suspected aortic dissection
  • Known relevant hematological deviations: Hb <10 g/dl, Platelets <50000.
  • Known severe liver disease, severe renal failure
  • Pregnancy/breastfeeding.
  • Allergy / Hypersensitivity.

研究者

发起方
Fluid Research Fund

相似试验